Immunogenic Research Foundation :: Scientific Advisory Board :: Apsley

John W. Apsley II, MD(E), DC.

John W. Apsley II, MD(E), DC.

Dr. John Apsley has been involved with clinical research specializing in cellular regeneration and accelerated wound repair for the past 30 years. He perfected a unique and novel rapid regenerative electrical acupuncture technique in 1995. Utilizing silver needles wired to micro-current transcutaneous electrical nerve stimulation (uAmp-T.E.N.S.), these techniques induced high-rate wound repair. When used with picoscalar silver particles, inducible and reproducible epigenic events are achieved. Research into anti-aging medicine led Dr. Apsley to postulate that the human aging process is being accelerated in our modern age by insidious chronic infectious processes. From these observations, he approaches anti-aging medicine in a two-step process: first remove the infectious processes safely and efficaciously; and second, induce regenerative effects at the cellular level across aging tissues.

Dr. Apsley holds degrees in nutrition - B.S., chiropractic - D.C., and medicine – MD(E). Certifications include Independent Medical Examiner (IME), Spinal Disability Evaluator (CSDE), and Insurance Claims Reviewer (IRC). He is also a qualified instructor of Electrodermal Scanning and Darkfield Microscopy. Dr. Apsley earned his degree in nutrition from Donsbach University in 1981. He graduated Magna Cum Laud from Life Chiropractic College, located in Marietta, GA., and in 1984, and went on to earn his medical degree in eclectic and integrative medicine from The British West Indies Medical College, in Grand Turk, Turks & Caicos, in 1987. In 1994 he became a licensed acupuncturist (Diplomate Ac.) in the state of Alabama. He has practiced primarily as a: licensed naturopathic physician specializing in oncology, chiropractic physician specializing in A.K. and, trauma acupuncture specialist.

Dr. Apsley has written or co-authored five books, including a best seller entitled The Regeneration Effect. Additionally, he has published and lectured extensively on the techniques of human regenerative techniques in medicine within the clinical setting. Presently, he also serves as IMREF’s chief editor for various articles published within the medical field that report on various clinical investigations conducted by IMREF’s medical scientific advisory board membership. (See list of publications below.)

As Executive Director of IMREF, Dr. Apsley has established two fundamental and compelling funding goals for interested philanthropists. The first is to establish within the global medical community that nanotechnology has rendered silver into an unparalleled antimicrobial agent that shows great promise to surpass the entire class of antibiotic agents currently known. The second is to establish within the field of the nanosciences that sub-nanoscalar silver will usher in a new era to modern medicine; namely, proven techniques of regenerative medicine. IMREF’s mission is to reveal to the world that silver rendered into sub-nanometer size clusters suspended in water (technically referred to as uniform picoscalar oligodynamic silver hydrosol or UPOSH), could offer the world dramatic and unprecedented results in both the control of the most lethal infectious processes, as well as anti-aging medicine. With the help of the silver industry at large, IMREF and its highly experienced and competent research team stands alone as the leader in this specialized field of research.

Currently, Dr. Apsley resides with his wife Linda, and family of seven children, in Fall City, Washington. Their oldest son is 26 years of age, and their youngest child is seven years old.

Presentations & Power Point Illustrations

June 16th, 2003 – American Academy of Environmental Medicine (AAEM) Summer Conference. Chief Editor for Eric Rentz, DO, MS, COMM, Power Point Presentation – Oligodynamic Ag+ As A Broad-Spectrum Antimicrobial For the Treatment of Fibromyalgia & CFIDS.

July 29th – August 2nd, 2003 – Clarion Hotel-Universal, Orlando, Florida, Florida Chiropractic Physicians’ Association (FCPA) Symposium 2003 – (1) Jarisch-Herxheimer Effects; (2) Chronic Fatigue – Part IV: Fibromyalgia and Special Problems Relating to Remineralization. Chief Editor to the following presentations at the FCPA symposium: (A) Eric J. Rentz, DO, MS, COMM: Chronic Fatigue – Part I. Effective Immune Strategies for Mycoplasma: An Integrative Approach for Conquering A Most Resistant Organism; (B) Eric J. Rentz, DO, MS, COMM: Cancer Parts I & II: Effective Cancer Support in the Integrative Practice; (C) Eric J. Rentz, DO, MS, COMM: Anti-Aging Part I: Using Hormone Replacement Therapy As Your First Step In Integrative Anti-Aging Intervention (With A Special Commentary on Osteoporosis); (D) Donald Coles, D.O.M. A.P.: Dermal and Visceral Regeneration with Meridian Therapy.

September 27th - 30th, 2006 - Panyu Hotel, Panyu, Guangzhou, China, 5th International Silver Conference Nanotechnology Discovers Universal Pathogen Solution – Uniform Picoscalar Oligodynamic Silver Hydrosol (UPOSH)

November 21st, 2006 - Minneapolis, MN, USA: Boston Scientific Lecture to Senior Researchers, “Picoscalar Oligodynamic Ag+ Induction of Human Epigenesis.”

June 22 – 24th, 2007 - Irvine CA, USA: LIA Foundation’s First Annual Lyme-Autism Connection Conference, “Fundamental Causations to Autism, Mercury Intoxication and Lyme Disease are Addressed by First Restoring the Colloidal Millieu and then by Treatment with Oligodynamic Silver – Introducing UPOSH Pulsed Inducible Cytokine Immunorehabilitation Technique (PICIT).”

October 20th, 2007 - Paris, France: Immunogenic Research Foundation & Energetica Natura joint symposium: “First & Foremost - Restore the Gel State (Intracellular Milieu) for Cancer and Immunocompetence: The Keys to Successful Advanced Cancer Recovery.”

October 27th, 2007 – Dallas, Texas: Cavitat/Simoncini Oral Toxicology and Cancer Seminar – “Colloidal Milieu Priming with NaHCO3 and the Restoration of the High Gain Gel State with UPOSH and Other Metal Hydrosols.”


Publications

Books:

1984 Chief Editor – Applied Nutrition, by William P. Cottrille, DO. Blowing Rock, NC.

1984 Co-authored - “Constitution And Metabolic Body Types.” John Bandy, privately published, Blowing Rock, NC.

1990 Author - “Glandular Therapy, Volume I.” Privately Published, Ft. Lauderdale, Florida.

1991 Author - “Glandular Therapy Volume II.” Privately Published, Shelburne Falls, MA.

1995 Author - “The Genesis Effect: Spearheading Regeneration with Wild Blue Green Algae. Volume 1.” Published by Genesis Communications, LLC, Tuscaloosa, AL.

1996 Author - “The Regeneration Effect: A Professional Treatise on Self-Healing. Volume 2.” Published by Genesis Communications, LLC, Tuscaloosa, AL.

2000 Author - “Applied Constitutional Medicine: The Principles and Practices of Wm. Powell Cottrille, DO. Privately Published, Bellevue, WA.

2001 Author - “Biogenic Medicine: Health Care for the Twenty-First Century.” In: The Advanced Guide to Longevity Medicine, edited by Mitchell J. Ghen, DO, PhD, Published by Partners in Wellness, Landrum, SC, p. 45-56. ISBN: 1-890694-37-1. Library of Congress Cat. No. 2001086737.


Treatise, Monographs & Booklets:

2006: IMREF Treatise Part 1 – Management of Complex Metabolic Consequences in Chronic Infections with heavy Pathogen Loads and Synergistic Treatment with Uniform Picoscalar Oligodynamic Silver Hydrosol (UPOSH).

2006: IMREF Treatise Part 2 – Treatment Protocols for Acute and Chronic Infectious Processes using Uniform Picoscalar Oligodynamic Silver Hydrosol (UPOSH).

2006: Monograph - Picoscalar Oligodynamic Ag+ Induction of Human Epigenesis. Presentation before senior researchers at Boston Scientific, Minneapolis, MN, USA. © 2006 by Dr. John W. Apsley, II.

2007: IMREF Treatise Part 3 – UPOSH Master File: For Physicians, Attorneys, State Medical Boards, Metal Toxicologists & Pharmacologists.

2007: Lecture Notes Booklet – Fundamental Causations to Autism, Mercury Intoxication and Lyme Disease are Addressed by First Restoring the Colloidal Milieu and then by Treatment with Oligodynamic Silver – Introducing UPOSH Pulsed Inducible Cytokine Immunoregulation Technique (PICIT).

2007: Lecture Notes Booklet - : First & Foremost - Restore the Gel State (Intracellular Milieu) for Cancer and Immunocompetence: The Keys to Successful Advanced Cancer Recovery. Protocols for NaHCO3 + UPOSH Treatment.


Articles:

1995 Author – “Hydrochloric Acid Therapy: Also Known As Lymphatic Chelation.” Privately published, Tuscaloosa, Al.

2006 Chief Editor - Gordon E, Holtorf K. “Promising cure to URTI pandemics including the avian flu (H5N1): Has the final solution to the coming plagues been discovered?” Part I. Townsend Letter. 2006 Feb/March;#271-2:61-7.

2006 Chief Editor - Gordon E, Holtorf K. “Promising cure to URTI pandemics including the avian flu (H5N1): Has the final solution to the coming plagues been discovered?” Part II. Townsend Letter. 2006 April;#273:66-72.

2006 Co-author – “Has Nanotechnology Created A Universal Antimicrobial Agent?: Silver, Cancer & Infection Associations Part III.” © By John Apsley, DC, MD(E), Kent Holtorf, MD, Eric Gordon, MD, Wayne Anderson, ND, and Rashid Buttar, DO, FAAPM, FACAM, FAAIM. Part III. Townsend Letter. 2006 May;#274:95-8.

2006 Co-author - Dana Flavin, MD, MS (past Pharmacologist and Science Advisor to the Associate Bureau Director for Toxicology, Food & Drug Administration); and Dr. John W. Apsley, II, Executive Director of IMREF, “History and Impact Upon Silver in Medicine with the Emerging Nanosciences.” © 2006 by Immunogenic Research Foundation, Inc.

2006 Co-Author - Co-authors: Dana Flavin, MD, MS (past Pharmacologist and Science Advisor to the Associate Bureau Director for Toxicology, Food & Drug Administration); and Dr. John W. Apsley, II, Executive Director of IMREF, “Oligodynamics and Speciations of Silver-Based Drugs.” © 2006 by Immunogenic Research Foundation, Inc.

2006 Co-author - Dana Flavin, MD, MS (past Pharmacologist and Science Advisor to the Associate Bureau Director for Toxicology, Food & Drug Administration); and Dr. John W. Apsley, II, Executive Director of IMREF. “Pharmacology of UPOSH.” © 2006 by Immunogenic Research Foundation, Inc.

2006 Co-author - Dana Flavin, MD, MS (past Pharmacologist and Science Advisor to the Associate Bureau Director for Toxicology, Food & Drug Administration); and Dr. John W. Apsley, II, Executive Director of IMREF. “Safety Of Various Silver-Based Drug Speciations Including Nanoscalar and Sub-nanoscalar Silver Hydrosols.” © 2006 by Immunogenic Research Foundation, Inc.

2006 Co-author - Dana Flavin, MD, MS (past Pharmacologist and Science Advisor to the Associate Bureau Director for Toxicology, Food & Drug Administration); and Dr. John W. Apsley, II, Executive Director of IMREF. “Oligodynamic Silver as a Universal Pathogen Solution.” © 2006 by Immunogenic Research Foundation, Inc.

2006 Co-author - Dana Flavin, MD, MS (past Pharmacologist and Science Advisor to the Associate Bureau Director for Toxicology, Food & Drug Administration); and Dr. John W. Apsley, II, Executive Director of IMREF. “Therapeutic Index (T.I.) Of Nanoscalar and Sub-nanoscalar Silver Hydrosols.” © 2006 by Immunogenic Research Foundation, Inc.

2006 Co-author - Dana Flavin, MD, MS (past Pharmacologist and Science Advisor to the Associate Bureau Director for Toxicology, Food & Drug Administration); and Dr. John W. Apsley, II, Executive Director of IMREF. “Contraindications, Precautions And Best Practices Essential for UPOSH Therapy.” © 2006 by Immunogenic Research Foundation, Inc.

2006 Author – “Investigational Uniform Picoscalar Oligodynamic Silver Hydrosol (UPOSH) Protocol Proposal – For Educational/Confidential Use by IRB Members & Participants.” © 2006 Immunogenic Research Foundation, Inc. (IMREF).

2006 Author – “Has Nanotechnology Given Us The Latest Silver Bullet for Dealing with Our Most Serious Infections?” By John W. Apsley, II, DC, MD(E). IMREF Newsletter – August 2006. © 2006 by Immunogenic Research Foundation, Inc.

2006 Author - “Microbial Multi-Drug Resistance (MDR) And Oligodynamic Silver.” IMREF Newsletter – September 2006. © 2006 by Immunogenic Research Foundation, Inc.

2007 Author – “Colloidal Milieu Restoration.” IMREF Newsletter July 2007. © 2007 Immunogenic Research Foundation, Inc.

2007 Author - “Resolving the Confusion and Controversy Surrounding Silver in Medicine over the Past 88 Years.” IMREF Newsletter August 2007© 2007 by Immunogenic Research Foundation, Inc.

2007 Author – “A Review of Comprehensive Evaluations Concerning Pathogen Susceptibility to Oligodynamic Silver (Toward perfecting an Oligodynamic Germicidal Rating Scale – OGRS).” IMREF Newsletter October 2007. © 2007 by Immunogenic Research Foundation, Inc.

2007 Author – “Colloidal Milieu Restoration and UPOSH Pre-Loading Protocol Pertaining to Advanced Cancer & Chronic Infectious Diseases: 30 Day Pre-Loading + 2 Week Borrelia Treatment Schedule for average 75 kilos adult (adjust accordingly to patient weight and age; i.e., ½ dosages for the young ~ 37.5 kilos).” © 2007 by Immunogenic Research Foundation, Inc. (IMREF).

 
Privacy Notice  |  Terms & Conditions
© 2006 Immunogenic Research Foundation, Inc.